e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Hypoxic lung cancer-derived exosome decreases anticancer activity of NK cell by targeting CD226
Y. Hsu (Kaohsiung, Taiwan), . Hung (Kaohsiung, Taiwan), S. Jian (Kaohsiung, Taiwan)
Source:
International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency
Session:
New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency
Session type:
Thematic Poster
Number:
4056
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Hsu (Kaohsiung, Taiwan), . Hung (Kaohsiung, Taiwan), S. Jian (Kaohsiung, Taiwan). Hypoxic lung cancer-derived exosome decreases anticancer activity of NK cell by targeting CD226. 4056
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Induced expression of B7-H3 on the lung cancer cells and macrophages suppresses tumor-specific T cell immunity
Source: Annual Congress 2012 - New aspects of lung cancer biology
Year: 2012
N-terminal deletion augments the cell death-inducing activity of BAX in the adenoviral gene delivery to nonsmall cell lung cancers
Source: Eur Respir J 2002; 20: Suppl. 38, 14s
Year: 2002
Functional expressions of EGFP/LKB1 and its kinase domain induced apoptosis and enhanced chemosensitivity in lung cancer cell lines
Source: Eur Respir J 2004; 24: Suppl. 48, 5s
Year: 2004
Anti-tumour effects of coculture of dendritic cells with cytokine-induced killer cells against lung cancer
in vitro
and
in vivo
Source: Eur Respir J 2006; 28: Suppl. 50, 387s
Year: 2006
KPNB1-mediated PD-L1 nuclear translocation promotes non-small cell lung cancer cell proliferation via the Gas6/MerTK signalling pathway
Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Year: 2020
Involvement of Fas/FasL system in gemcitabine-induced lung cancer cell killing
Source: Annual Congress 2010 - Pathology of lung cancer
Year: 2010
The expression of PD-L1 on the lung cancer cell and its role in T cell anergy
Source: Eur Respir J 2007; 30: Suppl. 51, 289s
Year: 2007
Toll-like receptor 3 is up-regulated and enhances anti-proliferative function in human non-small cell lung cancer
Source: Annual Congress 2008 - Lung cancer and other malignant diseases involving the lungs
Year: 2008
IRP2 as a potential modulator of cell proliferation, apoptosis and prognosis in nonsmall cell lung cancer
Source: Eur Respir J , 49 (4) 1600711; DOI: 10.1183/13993003.00711-2016
Year: 2017
Prx1 provides resistance to docetaxel-induced apoptosis in lung cancer cells
Source: Annual Congress 2010 - Prognostic factors for lung cancer
Year: 2010
Specific plasmids encoding shRNA molecules directed against growth factor receptors in cell proliferation inhibition and induction phenotype changes relevant to enhancement of anti-tumor immunity. Model of human non-small (NSCLC) and small (SCLC) cell lung cancer lines
Source: Annual Congress 2010 - Pathology of lung cancer
Year: 2010
Inhibitory effects of shRNA targeting layilin on adhesion and invasion behavior of human lung carcinoma cell A549 induced by hyaluronan
in vitro
Source: Eur Respir J 2006; 28: Suppl. 50, 855s
Year: 2006
The role of NHE-1 on multidrug-resistance mechanisms of human small cell lung cancer cells
Source: Eur Respir J 2007; 30: Suppl. 51, 537s
Year: 2007
Lower APCR correlates with apoptotic activation of CD8+T cells in non-small cell lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 356s
Year: 2004
Heparins inhibit lung cancer cells proliferation in vitro
Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology
Year: 2008
Blocking VEGF does not induce proapoptotic effects in the NSCLC cell line A549
Source: Annual Congress 2010 - New insights in the pathology of lung cancer
Year: 2010
Proteinase inhibition regulates the anti-tumor activity of PAI-1 towards lung and prostate cancer cells
Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics
Year: 2011
Inhibition of B7-H4 gene expression by RNA interference (RNAi) in lung cancer A549 cell line
Source: Annual Congress 2011 - Progress in pathology of lung cancer
Year: 2011
Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis in resected non–small cell lung cancer
Source: Annual Congress 2009 - Pathogenesis of lung cancer
Year: 2009
Gemcitabine sensitizes lung cancer cells to Fas /Fas ligand system-mediated killing
Source: Annual Congress 2011 - Treatment of lung cancer
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept